CancerNCT07253792
Cancer Screening Training for Academics
A study testing Cancer training in people with Cancer, run by KTO Karatay University at 1 site in Turkey (Türkiye).
Trial summary
Purpose: The purpose of this research is to examine the effect of cancer screening education on individuals' knowledge levels regarding cancer screening and their rates of utilization of primary health care services. Method: The research was conducted using a parallel group pretest-posttest experimental design. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Cancer
- What is being tested?
- Cancer training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 71 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Apr 2025to 1 Jun 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Be employed full-time at the university,
- Be able to read and understand Turkish,
- Not have received any cancer screening training in the last 6 months
Who cannot join
- Those who did not participate in the training or participated incompletely,
- Those with incomplete information in the pre-test or post-test data,
- Those who have been diagnosed with cancer and are undergoing treatment
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Cancer Screening Training Provided to Academics at a Foundation University on Cancer Screening Knowledge Levels and Family Health Center Utilization Rates
Purpose: The purpose of this research is to examine the effect of cancer screening education on individuals' knowledge levels regarding cancer screening and their rates of utilization of primary health care services.
Method: The research was conducted using a parallel group pretest-posttest experimental design. The study, conducted at a foundation university between April and May 2025, included 71 academics selected using simple random sampling. The intervention group received structured cancer screening education for four weeks. Data will be collected using a Personal Information Form and the Cancer Screening Knowledge Scale (CSKS), and will be analyzed using appropriate statistical methods.
- Conditions
- Cancer
- Being tested
- Cancer training
- Keywords
- Health Education, knowledge, Primary Health Care, Health Professional, Nursing
- Medical subject headings
- Neoplasms, Health Education
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cancer trainingBehavioural
Pre-test data, including the Personal Information Form and the Cancer Screening Information Scale, were collected from participants in the intervention group before the training began. The pre-test took approximately 5-10 minutes to complete. Subsequently, this group received training on cancer screening and Family Health Centre use once a week for a total of four weeks. Following the completion of the training, a post-test was administered at the end of the fourth week.
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Before the training began, baseline data were collected from participants in the intervention group, including a Personal Information Form, a Cancer Screening Awareness Questionnaire for Family Health Centers, and a Cancer Screening Knowledge Scale. Completing the baseline assessment took approximately 5-10 minutes. Subsequently, this group received a 15-minute face-to-face structured training session on cancer screening and the use of Family Health Centers. The post-test was administered two months after the training was completed. Receives: Behavioral: Cancer training |
| control | No intervention | No training was provided to participants in the control group. Participants in this group were only asked to complete a Personal Information Form at the beginning of the study, and final test data was collected at the end of the two months |
What is being measured
The primary outcome is the main question the study is designed to answer.
Family health centre utilisation rate
Awareness Rate of Cancer Screenings at Family Health Centers: The percentage of participants who reported having utilized the services provided by a family health center within a specific time period. This rate includes visits for preventive care, screening, diagnosis, treatment, or follow-up services, as defined in the study protocol.
Measured: From baseline to 2 months after training
Cancer knowledge level
Cancer knowledge level: The score obtained from the Cancer Screening Knowledge Scale (CSKS), which measures participants' knowledge about cancer screening methods, recommended screening intervals, and target populations. Higher scores indicate a greater level of knowledge, as defined by the study protocol.
Measured: From baseline to 2 month post-training
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Nov 2025
- Study start1 Apr 2025
- Primary completion1 Jun 2025
- Study completion1 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Before the training began, baseline data were collected from participants in the intervention group, including a Personal Information Form, a Cancer Screening Awareness Questionnaire for Family Health Centers, and a Cancer Screening Knowledge Scale. Completing the baseline assessment took approximately 5-10 minutes. Subsequently, this group received a 15-minute face-to-face structured training session on cancer screening and the use of Family Health Centers. The post-test was administered two months after the training was completed.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 71 participants (actual)
Sponsor and investigators
- Lead sponsor
- KTO Karatay University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Naciye Esra Koyuncu, KTO Karatay University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07253792
- Sponsor's protocol ID
- 14.04.2025-E.107676
- Status last verified
- Nov 2025
- First submitted
- 1 Aug 2025
- Last updated
- 9 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: "Individual participant data will not be shared due to privacy concerns and institutional ethical restrictions. The dataset includes identifiable information that cannot be fully anonymized.
Publications
Dagar, M., Upadhyay, P., & Kumar, P. (2025). Assessing Cancer Awareness and Knowledge Among Healthcare Professionals in a Tertiary Care Teaching Hospital, Bareilly. SRMS JOURNAL OF MEDICAL SCIENCE, 10(Suppl1), S13-S19. https://doi.org/10.21761/JMS.V10ISUPPL.04
Study at a glance
From the registry record, last updated by the sponsor on 9 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Cancer Screening Training Provided to Academics at a Foundation University on Cancer Screening Knowledge Levels and Family Health Center Utilization Rates
- ClinicalTrials.gov ID
- NCT07253792
- Acronym / sponsor ID
- 14.04.2025-E.107676
- Conditions
- Cancer
- Keywords
- Health Education, knowledge, Primary Health Care, Health Professional, Nursing
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 71 participants (actual)
- Lead sponsor
- KTO Karatay UniversityUniversity, hospital or other
- Study start
- 1 Apr 2025 (actual)
- Primary completion
- 1 Jun 2025 (actual)
- Study completion
- 1 Jun 2025 (actual)
- First posted
- 28 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Purpose: The purpose of this research is to examine the effect of cancer screening education on individuals' knowledge levels regarding cancer screening and their rates of utilization of primary health care services.
Method: The research was conducted using a parallel group pretest-posttest experimental design. The study, conducted at a foundation university between April and May 2025, included 71 academics selected using simple random sampling. The intervention group received structured cancer screening education for four weeks. Data will be collected using a Personal Information Form and the Cancer Screening Knowledge Scale (CSKS), and will be analyzed using appropriate statistical methods.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Before the training began, baseline data were collected from participants in the intervention group, including a Personal Information Form, a Cancer Screening Awareness Questionnaire for Family Health Centers, and a Cancer Screening Knowledge Scale. Completing the baseline assessment took approximately 5-10 minutes. Subsequently, this group received a 15-minute face-to-face structured training session on cancer screening and the use of Family Health Centers. The post-test was administered two months after the training was completed.
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Behavioral: Cancer trainingBefore the training began, baseline data were collected from participants in the intervention group, including a Personal Information Form, a Cancer Screening Awareness Questionnaire for Family Health Centers, and a Cancer Screening Knowledge Scale. Completing the baseline assessment took approximately 5-10 minutes. Subsequently, this group received a 15-minute face-to-face structured training session on cancer screening and the use of Family Health Centers. The post-test was administered two months after the training was completed. |
| control | No intervention | –No training was provided to participants in the control group. Participants in this group were only asked to complete a Personal Information Form at the beginning of the study, and final test data was collected at the end of the two months |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (3 listed)
- Be employed full-time at the university,
- Be able to read and understand Turkish,
- Not have received any cancer screening training in the last 6 months
Key exclusion criteria (3 listed)
- Those who did not participate in the training or participated incompletely,
- Those with incomplete information in the pre-test or post-test data,
- Those who have been diagnosed with cancer and are undergoing treatment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cancer trainingPre-test data, including the Personal Information Form and the Cancer Screening Information Scale, were collected from participants in the intervention group before the training began. The pre-test took approximately 5-10 minutes to complete. Subsequently, this group received training on cancer screening and Family Health Centre use once a week for a total of four weeks. Following the completion of the training, a post-test was administered at the end of the fourth week. | Behavioural | Intervention |
Primary outcome
Family health centre utilisation rate
Time frame: From baseline to 2 months after training
Awareness Rate of Cancer Screenings at Family Health Centers: The percentage of participants who reported having utilized the services provided by a family health center within a specific time period. This rate includes visits for preventive care, screening, diagnosis, treatment, or follow-up services, as defined in the study protocol.
Cancer knowledge level
Time frame: From baseline to 2 month post-training
Cancer knowledge level: The score obtained from the Cancer Screening Knowledge Scale (CSKS), which measures participants' knowledge about cancer screening methods, recommended screening intervals, and target populations. Higher scores indicate a greater level of knowledge, as defined by the study protocol.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jun 2026.
- BackgroundDagar, M., Upadhyay, P., & Kumar, P. (2025). Assessing Cancer Awareness and Knowledge Among Healthcare Professionals in a Tertiary Care Teaching Hospital, Bareilly. SRMS JOURNAL OF MEDICAL SCIENCE, 10(Suppl1), S13-S19. https://doi.org/10.21761/JMS.V10ISUPPL.04
- Individual participant dataSharing planned: No. "Individual participant data will not be shared due to privacy concerns and institutional ethical restrictions. The dataset includes identifiable information that cannot be fully anonymized.
Related trials for Cancer
Not yet recruitingPhase 1/2
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Thyroid Cancer
RecruitingPhase 1/2
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
RecruitingPhase 3
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
Ovarian Cancer, Ovarian Neoplasms
RecruitingPhase 1/2
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Lymphoma, Non-Hodgkin Lymphoma
RecruitingPhase 3
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cancer training in people with Cancer, run by KTO Karatay University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Family health centre utilisation rate (time frame: From baseline to 2 months after training). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07253792, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2026.